Point72 Hong Kong’s Disc Medicine IRON Stock Holding History

Point72 Hong Kong’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3	Closed	–	–	2125
2021 Q3	$0	Sell	3 -18	-86%	-$2.46K	﹤0.01%	2216
2021 Q2	$4K	Buy	+21	New	+$6.91K	﹤0.01%	1807

Other funds holding IRON

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

FCOMV

Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Hong Kong's IRON Position: Q4 2021 in Review

Point72 Hong Kong sold out of Disc Medicine (IRON) in Q4 2021, closing a stake of 3 shares.

Point72 Hong Kong first reported a position in IRON in Q2 2021 and held it in 2 quarters. The position peaked at $4K in Q2 2021. 62 funds tracked by Wall St. Rank hold IRON as of Q4 2021.

Point72 Hong Kong reported no remaining Disc Medicine position as of Q4 2021 after selling out during the quarter.
Point72 Hong Kong sold 3 Disc Medicine shares in Q4 2021.
Point72 Hong Kong first reported a position in Disc Medicine in Q2 2021 and held it in 2 quarters.
Point72 Hong Kong's Disc Medicine position peaked at $4K in Q2 2021.
62 funds tracked by Wall St. Rank held Disc Medicine as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.